Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisor...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf56 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f7dba004c3344d4cbafb00588e41bf56 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f7dba004c3344d4cbafb00588e41bf562021-12-02T14:39:26ZAuthor Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells10.1038/s41467-018-05468-y2041-1723https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf562018-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05468-yhttps://doaj.org/toc/2041-1723The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.M. FehlingsY. SimoniH. L. PennyE. BechtC. Y. LohM. M. GubinJ. P. WardS. C. WongR. D. SchreiberE. W. NewellNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-1 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q M. Fehlings Y. Simoni H. L. Penny E. Becht C. Y. Loh M. M. Gubin J. P. Ward S. C. Wong R. D. Schreiber E. W. Newell Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells |
description |
The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article. |
format |
article |
author |
M. Fehlings Y. Simoni H. L. Penny E. Becht C. Y. Loh M. M. Gubin J. P. Ward S. C. Wong R. D. Schreiber E. W. Newell |
author_facet |
M. Fehlings Y. Simoni H. L. Penny E. Becht C. Y. Loh M. M. Gubin J. P. Ward S. C. Wong R. D. Schreiber E. W. Newell |
author_sort |
M. Fehlings |
title |
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells |
title_short |
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells |
title_full |
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells |
title_fullStr |
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells |
title_full_unstemmed |
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells |
title_sort |
author correction: checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific cd8+ t cells |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf56 |
work_keys_str_mv |
AT mfehlings authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT ysimoni authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT hlpenny authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT ebecht authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT cyloh authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT mmgubin authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT jpward authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT scwong authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT rdschreiber authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT ewnewell authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells |
_version_ |
1718390631056801792 |